Clinical trial
Creation and Implementation a Method for Breast Reconstruction After Radical Surgery Using Decellularized Xenomatrix in Combination With Lymphovenous Anastomosis in Breast Cancer.
NCT07782801 is registered in ClinicalTrials.gov with National Research Oncology and Transplantology Center, Kazakhstan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Creation and Implementation a Method for Breast Reconstruction After Radical Surgery Using Decellularized Xenomatrix in Combination With Lymphovenous Anastomosis in Breast Cancer.
- Lead sponsor
- National Research Oncology and Transplantology Center, Kazakhstan
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 15, 2025
- Completion date
- January 1, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brest cancer